Fluid biopsy for Circulating Tumor Cell identification in Patients with early and late stage Non-Small Cell Lung Cancer; a glimpse into lung cancer biology

Circulating tumor cell (CTC) counts are an established prognostic marker in metastatic prostate, breast, and colorectal cancer, and recent data suggests a similar role in late stage non-small cell lung cancer (NSCLC). However, due to sensitivity constraints in current enrichment-based CTC detection...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wendel, Marco, Bazhenova, Lyudmila, Boshuizen, Rogier, Kolatkar, Anand, Honnatti, Meghana, Cho, Edward H., Marrinucci, Dena, Sandhu, Ajay, Perricone, Anthony, Thistlethwaite, Patricia, Bethel, Kelly, Nieva, Jorge, van den Heuvel, Michel, Kuhn, Peter
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3387995/
https://ncbi.nlm.nih.gov/pubmed/22307026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1088/1478-3967/9/1/016005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars